Trial site
Seoul
- 14running trials
- 15closed trials
The trials here
What the 29 trials at this site are about, from their registry records.
- Conditions
- Asthma5 trials
- Multiple myeloma4 trials
- Multiple sclerosis4 trials
- Gastric and oesophageal cancer3 trials
- Lung cancer3 trials
- COPD2 trials
- Crohn's disease2 trials
- Metastatic breast cancer2 trials
- Chronic rhinosinusitis with nasal polyps1 trial
- Colorectal cancer1 trial
- Haemophilia1 trial
- Head and neck cancer1 trial
- and 4 more
- Phase
- Phase 213 trials
- Phase 311 trials
- Phase 12 trials
- Phase 42 trials
- Phase 1/21 trial
- Status
- Active, not recruiting8 trials
- Terminated8 trials
- Completed7 trials
- Recruiting4 trials
- Enrolling by invitation2 trials
- Lead sponsor
- Sanofi29 trials
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
Enrolling by invitation
Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Enrolling by invitation
Active, not recruiting
Active, not recruiting
Recruiting
Isatuximab in Combination With Novel Agents in RRMM - Master Protocol
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Crohn's disease2 recruiting
- Multiple myeloma2 recruiting
- Asthma1 recruiting
- COPD1 recruiting
Closed trials
Recruiting
Completed
Completed
Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma
Completed
Proof of Concept Study of Rilzabrutinib in Adult Participants With Moderate-to-severe Asthma
Completed
Terminated
Terminated
Terminated
Terminated
Terminated
Completed
Terminated
Terminated
First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL
Completed
Terminated
Site data: ClinicalTrials.govUpdated 18 Nov 2026